- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Structure and inhibition of the human lysosomal transporter Sialin ; volume:15 ; number:1 ; day:23 ; month:5 ; year:2024 ; pages:1-11 ; date:12.2024
Nature Communications ; 15, Heft 1 (23.5.2024), 1-11, 12.2024
- Creator
-
Schmiege, Philip
Donnelly, Linda
Elghobashi-Meinhardt, Nadia
Lee, Chia-Hsueh
Li, Xiaochun
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41467-024-48535-3
- URN
-
urn:nbn:de:101:1-2408020924583.434624079010
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:48 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Schmiege, Philip
- Donnelly, Linda
- Elghobashi-Meinhardt, Nadia
- Lee, Chia-Hsueh
- Li, Xiaochun
- SpringerLink (Online service)
Other Objects (12)
Structure of the human dopamine transporter and mechanisms of inhibition
An inventory of lysosomal ABC transporters
A Genetic Screen for Investigating the Human Lysosomal CystineTransporter, Cystinosin
Functional reconstitution of the human lysosomal peptide transporter TAPL reveals the substrate specificity
Regulation of lysosomal ion homeostasis by channels and transporters
Inhibition of endo-lysosomal function exacerbates vascular calcification
Crystal structures of human lysosomal EPDR1 reveal homology with the superfamily of bacterial lipoprotein transporters
Structural and functional characterization of the lysosomal peptide transporter TAPL
Characterization of the lysosomal targeting of the ABC transporter TAPL
Structure of human drug transporters OATP1B1 and OATP1B3
TFEB-mediated lysosomal biogenesis and lysosomal drug sequestration confer resistance to MEK inhibition in pancreatic cancer
Transport and inhibition mechanism of the human SGLT2–MAP17 glucose transporter
Structure of the human dopamine transporter and mechanisms of inhibition
An inventory of lysosomal ABC transporters
A Genetic Screen for Investigating the Human Lysosomal CystineTransporter, Cystinosin
Functional reconstitution of the human lysosomal peptide transporter TAPL reveals the substrate specificity
Regulation of lysosomal ion homeostasis by channels and transporters
Inhibition of endo-lysosomal function exacerbates vascular calcification
Crystal structures of human lysosomal EPDR1 reveal homology with the superfamily of bacterial lipoprotein transporters
Structural and functional characterization of the lysosomal peptide transporter TAPL
Characterization of the lysosomal targeting of the ABC transporter TAPL
Structure of human drug transporters OATP1B1 and OATP1B3
TFEB-mediated lysosomal biogenesis and lysosomal drug sequestration confer resistance to MEK inhibition in pancreatic cancer
Transport and inhibition mechanism of the human SGLT2–MAP17 glucose transporter
Structure of the human dopamine transporter and mechanisms of inhibition
An inventory of lysosomal ABC transporters
A Genetic Screen for Investigating the Human Lysosomal CystineTransporter, Cystinosin
Functional reconstitution of the human lysosomal peptide transporter TAPL reveals the substrate specificity
Regulation of lysosomal ion homeostasis by channels and transporters
Inhibition of endo-lysosomal function exacerbates vascular calcification
Crystal structures of human lysosomal EPDR1 reveal homology with the superfamily of bacterial lipoprotein transporters
Structural and functional characterization of the lysosomal peptide transporter TAPL
Characterization of the lysosomal targeting of the ABC transporter TAPL
Structure of human drug transporters OATP1B1 and OATP1B3
TFEB-mediated lysosomal biogenesis and lysosomal drug sequestration confer resistance to MEK inhibition in pancreatic cancer